Yüklüyor......
Clinical Utility of Eribulin Mesylate in the Treatment of Breast Cancer: A Chinese Perspective
Eribulin mesylate, a synthetic derivative of the anti-mitotic agent halichondrin B, has a unique tubulin-based mechanism of action that is distinct from other anti-microtubule agents including taxanes and vinca alkaloids. Consistent with this unique activity, eribulin has shown clinical efficacy in...
Kaydedildi:
| Yayımlandı: | Breast Cancer (Dove Med Press) |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7917473/ https://ncbi.nlm.nih.gov/pubmed/33658845 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BCTT.S231298 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|